153 related articles for article (PubMed ID: 16005427)
1. Epigallocatechin gallate inhibits HIF-1alpha degradation in prostate cancer cells.
Thomas R; Kim MH
Biochem Biophys Res Commun; 2005 Aug; 334(2):543-8. PubMed ID: 16005427
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible factor 1alpha and 1beta proteins share common signaling pathways in human prostate cancer cells.
Zhong H; Hanrahan C; van der Poel H; Simons JW
Biochem Biophys Res Commun; 2001 Jun; 284(2):352-6. PubMed ID: 11394885
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of hypoxia inducible factor-1alpha in rat and human prostate cancer.
Zhong H; Agani F; Baccala AA; Laughner E; Rioseco-Camacho N; Isaacs WB; Simons JW; Semenza GL
Cancer Res; 1998 Dec; 58(23):5280-4. PubMed ID: 9850048
[TBL] [Abstract][Full Text] [Related]
4. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
5. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
[TBL] [Abstract][Full Text] [Related]
6. Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha).
Anastasiadis AG; Ghafar MA; Salomon L; Vacherot F; Benedit P; Chen MW; Shabsigh A; Burchardt M; Chopin DK; Shabsigh R; Buttyan R
J Cancer Res Clin Oncol; 2002 Jul; 128(7):358-62. PubMed ID: 12136249
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis.
Zhong H; Semenza GL; Simons JW; De Marzo AM
Cancer Detect Prev; 2004; 28(2):88-93. PubMed ID: 15068831
[TBL] [Abstract][Full Text] [Related]
9. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α.
He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X
Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117
[TBL] [Abstract][Full Text] [Related]
11. Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation.
Fu XS; Choi E; Bubley GJ; Balk SP
Prostate; 2005 May; 63(3):215-21. PubMed ID: 15538748
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor-1 in human breast and prostate cancer.
Kimbro KS; Simons JW
Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
[TBL] [Abstract][Full Text] [Related]
13. A novel approach of proteomics and transcriptomics to study the mechanism of action of the antioxidant-iron chelator green tea polyphenol (-)-epigallocatechin-3-gallate.
Weinreb O; Amit T; Youdim MB
Free Radic Biol Med; 2007 Aug; 43(4):546-56. PubMed ID: 17640565
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible factor-1alpha accumulation in the brain after experimental intracerebral hemorrhage.
Jiang Y; Wu J; Keep RF; Hua Y; Hoff JT; Xi G
J Cereb Blood Flow Metab; 2002 Jun; 22(6):689-96. PubMed ID: 12045667
[TBL] [Abstract][Full Text] [Related]
15. Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression.
Zagzag D; Zhong H; Scalzitti JM; Laughner E; Simons JW; Semenza GL
Cancer; 2000 Jun; 88(11):2606-18. PubMed ID: 10861440
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of epigallocatechin-3-gallate on cell proliferation and the expression of HIF-1α and P-gp in the human pancreatic carcinoma cell line PANC-1.
Zhu Z; Wang Y; Liu Z; Wang F; Zhao Q
Oncol Rep; 2012 May; 27(5):1567-72. PubMed ID: 22367292
[TBL] [Abstract][Full Text] [Related]
17. Normoxic stabilization of hypoxia-inducible factor-1alpha by modulation of the labile iron pool in differentiating U937 macrophages: effect of natural resistance-associated macrophage protein 1.
Knowles HJ; Mole DR; Ratcliffe PJ; Harris AL
Cancer Res; 2006 Mar; 66(5):2600-7. PubMed ID: 16510578
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-stimulated vascular endothelial growth factor production in human nasal polyp fibroblasts: effect of epigallocatechin-3-gallate on hypoxia-inducible factor-1 alpha synthesis.
Lin SK; Shun CT; Kok SH; Wang CC; Hsiao TY; Liu CM
Arch Otolaryngol Head Neck Surg; 2008 May; 134(5):522-7. PubMed ID: 18490575
[TBL] [Abstract][Full Text] [Related]
19. HIF hydroxylation and cellular oxygen sensing.
Metzen E; Ratcliffe PJ
Biol Chem; 2004; 385(3-4):223-30. PubMed ID: 15134335
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-inducible factor-1alpha induces the epithelial-mesenchymal transition of human prostatecancer cells.
Luo Y; He DL; Ning L; Shen SL; Li L; Li X
Chin Med J (Engl); 2006 May; 119(9):713-8. PubMed ID: 16701010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]